Dylan-Hyde Tyler

Insider CIK 1682027 · CRSP Chief Legal Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CRSP CRISPR Therapeutics AG	M Exercise deriv	2018-01-16	2018-01-18	1,110	—	$0	36,663	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2018-01-16	2018-01-18	19,890	—	$0	5,237	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2018-01-16	2018-01-18	19,890	$28.10	$558.9K	25,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2018-01-16	2018-01-18	45,000	$28.00	$1.26M	25,204	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2018-01-16	2018-01-18	1,110	$12.57	$14.0K	26,314	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2018-01-16	2018-01-18	19,890	$12.57	$250.0K	45,094	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2018-01-16	2018-01-18	1,110	$28.24	$31.3K	25,204	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2018-01-02	2018-01-04	6,490	—	$0	37,773	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2018-01-02	2018-01-04	1,510	—	$0	25,157	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2018-01-02	2018-01-04	8,000	$12.57	$100.6K	78,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2018-01-02	2018-01-04	30,000	$20.55	$616.5K	70,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2018-01-02	2018-01-04	8,000	$25.75	$206.0K	70,204	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2017-12-29	2018-01-02	9,070	—	$0	44,263	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2017-12-29	2018-01-02	6,230	—	$0	58,070	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-12-29	2018-01-02	15,000	$22.68	$340.2K	100,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-12-29	2018-01-02	1,070	$21.75	$23.3K	123,204	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2017-12-29	2018-01-02	9,070	$12.57	$114.0K	124,274	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-12-29	2018-01-02	6,230	$21.75	$135.5K	115,204	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2017-12-29	2018-01-02	6,230	$14.43	$89.9K	121,434	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-12-29	2018-01-02	8,000	$23.76	$190.1K	115,204	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise deriv	2017-12-28	2018-01-02	700	—	$0	64,300	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-12-28	2018-01-02	700	$21.75	$15.2K	115,204	SEC↗
CRSP CRISPR Therapeutics AG	M Exercise	2017-12-28	2018-01-02	700	$14.43	$10.1K	115,904	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-12-22	2017-12-27	15,000	$20.55	$308.3K	115,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-12-15	2017-12-19	15,000	$18.90	$283.5K	130,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-08-08	2017-08-08	1,313	$18.60	$24.4K	153,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-08-07	2017-08-08	13,210	$18.56	$245.2K	154,517	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-08-04	2017-08-08	477	$18.55	$8.8K	167,727	SEC↗
CRSP CRISPR Therapeutics AG	A Award deriv	2017-06-15	2017-06-19	65,000	—	$0	65,000	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-05-01	2017-05-03	1,852	$16.61	$30.8K	168,204	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-28	2017-04-28	4,912	$16.62	$81.6K	170,056	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-27	2017-04-28	13,527	$16.84	$227.8K	174,968	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-26	2017-04-28	3,200	$16.76	$53.6K	180,495	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-25	2017-04-25	4,800	$16.87	$81.0K	183,695	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-24	2017-04-25	3,522	$16.44	$57.9K	188,495	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-21	2017-04-25	3,010	$17.02	$51.2K	192,017	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-20	2017-04-21	2,937	$17.37	$51.0K	195,027	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-19	2017-04-21	4,930	$17.49	$86.2K	200,274	SEC↗
CRSP CRISPR Therapeutics AG	S Sale	2017-04-19	2017-04-21	2,310	$18.58	$42.9K	197,964	SEC↗